Acer Therapeutics Inc (NASDAQ:ACER) Stock Sees Bullish Move: Here is Why

October 7, 2021

Positive news with regards to any product in a pharmaceutical company’s pipeline can prove to be a big positive for its stock and hence, it was no surprise that the Acer Therapeutics Inc (NASDAQ:ACER) stock rallied by as much as 16.50% yesterday. The rally in the stock came about after the company made a major joint announcement with its collaboration partner Relief Therapeutics Holding SA with regards to its Urea…

Read More >>

Acer Therapeutics (NASDAQ:ACER) Stock Sees High Volatility: A Good Buy Now?

August 1, 2021

Pharmaceutical company focusing on acquisition and commercialisation of therapies for serious rare and life-threatening diseases, Acer Therapeutics (NASDAQ:ACER),announced on July 29, 2021 that after recent Type B meeting with U.S. FDA on Acer’s proposed EDSIVO development plan, the firm plans a pivotal clinical trial in patients with COL3A1+ vascular Ehlers-Danlos Syndrome. The firm in 2021 second half aims to submit protocol for prospective study in addition to investigational new drug…

Read More >>